Teachers Advisors’s Cardiff Oncology CRDF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-859
Closed -$71K 3132
2017
Q1
$71K Hold
859
﹤0.01% 3018
2016
Q4
$130K Buy
859
+191
+29% +$44.6K ﹤0.01% 2981
2016
Q3
$216K Hold
668
﹤0.01% 2857
2016
Q2
$218K Sell
668
-57
-8% -$19.6K ﹤0.01% 2858
2016
Q1
$243K Buy
725
+59
+9% +$20.1K ﹤0.01% 2718
2015
Q4
$259K Buy
666
+74
+13% +$29K ﹤0.01% 2771
2015
Q3
$242K Buy
592
+94
+19% +$49.2K ﹤0.01% 2812
2015
Q2
$364K Buy
+498
New +$353K ﹤0.01% 2714

Other funds holding CRDF

Teachers Advisors's CRDF Position: Q2 2017 in Review

Teachers Advisors sold out of Cardiff Oncology (CRDF) in Q2 2017, closing a stake of 859 shares — an estimated $71K sold.

Teachers Advisors first reported a position in CRDF in Q2 2015 and held it in 8 quarters. The position peaked at $364K in Q2 2015. 48 funds tracked by Wall St. Rank hold CRDF as of Q2 2017.

  • Teachers Advisors reported no remaining Cardiff Oncology position as of Q2 2017 after selling out during the quarter.
  • Teachers Advisors sold 859 Cardiff Oncology shares in Q2 2017, an estimated $71K.
  • Teachers Advisors first reported a position in Cardiff Oncology in Q2 2015 and held it in 8 quarters.
  • Teachers Advisors's Cardiff Oncology position peaked at $364K in Q2 2015.
  • 48 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2017.

Based on Teachers Advisors's 13F filing for Q2 2017, filed 10 Aug 2017.